Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.46 HKD
275.26 M HKD
1.71 B HKD
399.35 M
About ESSEX BIO-TECHNOLOGY
Sector
Industry
CEO
Hai Zhou Fang
Website
Headquarters
Hong Kong
Founded
1999
FIGI
BBG000JHS2L3
Essex Bio-Technology Ltd. is an investment holding company, which engages in the development, manufacture, and sale of biopharmaceutical products. It operates through the Ophthalmology and Surgical segments. The company was founded by Mia Je Ngiam in February 1999 and is headquartered in Hong Kong.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1061 is 2.87 HKD — it has decreased by −1.69% in the past 24 hours. Watch ESSEX BIO-TECHNOLOGY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ESSEX BIO-TECHNOLOGY stocks are traded under the ticker 1061.
1061 stock has risen by 7.41% compared to the previous week, the month change is a 3.57% rise, over the last year ESSEX BIO-TECHNOLOGY has showed a 23.71% increase.
1061 reached its all-time high on Mar 15, 2018 with the price of 9.60 HKD, and its all-time low was 0.51 HKD and was reached on May 23, 2012. View more price dynamics on 1061 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1061 stock is 4.29% volatile and has beta coefficient of 0.63. Track ESSEX BIO-TECHNOLOGY stock price on the chart and check out the list of the most volatile stocks — is ESSEX BIO-TECHNOLOGY there?
Today ESSEX BIO-TECHNOLOGY has the market capitalization of 1.65 B, it has increased by 5.45% over the last week.
Yes, you can track ESSEX BIO-TECHNOLOGY financials in yearly and quarterly reports right on TradingView.
ESSEX BIO-TECHNOLOGY is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
1061 net income for the last half-year is 157.44 M HKD, while the previous report showed 105.45 M HKD of net income which accounts for 49.30% change. Track more ESSEX BIO-TECHNOLOGY financial stats to get the full picture.
ESSEX BIO-TECHNOLOGY dividend yield was 3.61% in 2023, and payout ratio reached 18.65%. The year before the numbers were 1.55% and 16.55% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has 1.48 K employees. See our rating of the largest employees — is ESSEX BIO-TECHNOLOGY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ESSEX BIO-TECHNOLOGY EBITDA is 349.38 M HKD, and current EBITDA margin is 21.67%. See more stats in ESSEX BIO-TECHNOLOGY financial statements.
Like other stocks, 1061 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ESSEX BIO-TECHNOLOGY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ESSEX BIO-TECHNOLOGY technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ESSEX BIO-TECHNOLOGY stock shows the neutral signal. See more of ESSEX BIO-TECHNOLOGY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.